期刊文献+

针对趋化因子受体CCR5的SPA-WGA药物筛选方法 被引量:1

Drug screening model targeted to CCR5 based on[^(35)S]GTPγS scintillation proximity assay
下载PDF
导出
摘要 目的建立针对趋化因子受体CCR5的药物筛选SPA-WGA法[35S]GTPγS结合实验方法。方法通过降低SPA-WGA小球用量和对其他各种因素进行优化,如细胞膜用量、GDP浓度、体系孵育时间和样品连续测量时间,建立了SPA-WGA法[35S]GTPγS结合实验方法。结果最后优化得到实验条件为:100μl反应体系,0.1 mg SPA-WGA小球,10μgCHO-CCR5细胞膜,10μmol.L-1GDP和0.3 nmo.lL-1[35S]GTPγS,室温孵育1.5 h并且在1 200 m in之内完成所有样品测量。该法与传统抽滤法比较,测量得到RANTES的EC50分别为:1.40 nmol.L-1和2.90 nmol.L-1,测量得到SCH-C的IC50分别为:2.95 nmo.lL-1和2.73 nmo.lL-1,测量结果相似,均呈现出较好的剂量效应关系。利用该法筛选54个化合物,筛到3个IC50在1~10 nmol.L-1的化合物。这3个化合物是否具有H IV-1进入抑制剂的潜在开发价值,还有待体外抗H IV-1实验的进一步验证和筛选。结论此方法操作简便,灵敏性和重现性好,且可高通量和自动化,该法适用于能与Gi家族蛋白偶联的GPCR的高通量药物筛选。 Aim To develop a high throughput screening model targeted to CCR5 based on [ 35^ S ] GTPγS scintillation proximity assay. Methods Membranes expressing hCCR5 were incubated for 60 min with GDP, [ 35^ S] GTPγS and SPA-WGA beads with agonist or antagonist at room temperature. Then the beads were centrifuged and radioactivity was measured with scintillation counter. The assay, which measures the level of G protein activation following RANTES occupation of CCR5, can be used to determine the degree of agonism and the potency of compounds acting at CCRS. Result A new in vitro assay was established for the high throughput screening of CCR5 after minimizing of the amount of SPA-WGA beads and optimizing of other factors including the amount of CCR5 membranes, the concentration of GDP, the incubation time course and the counting time course.The EC50 value of RANTES or the IC50 value of SCH-C gained by using [ 35^ S] GTPγS scintillation proximity assay is good and is similar to using [ 35^ S ] GTPγS filtration assay. Among 54 small molecular compounds screened by using [ 35^S] GTPγS scintillation proximity assay, 3 compounds with IC50 values among 1 - 10 nmol · L ^- 1 will be further testified on their anti-HIV activities by using HIV-1 Neutralization Assays. Conclusion The [ 35^ S ] GTPγS scintillation proximity assay is easily and safely operated, automatable, economical and repeatable. And the assay is feasible by high throughput screening for the receptors coupling to Gi protein such as CCR5
出处 《中国药理学通报》 CAS CSCD 北大核心 2006年第10期1266-1271,共6页 Chinese Pharmacological Bulletin
基金 国家"十五"重大科技专项资助项目(No2004AA2Z3443) 上海市科学技术委员会科技攻关计划资助项目(No03DZ19216)
关键词 趋化因子受体CCR5 亲和闪烁法 [35^S]GTPγS结合 实验方法 高通量筛选 chemokine receptor CCRS scintillation proximity assay ( SPA ) [ 35^ S ] GTPγS binding assay high throughput screening
  • 相关文献

参考文献10

  • 1Amanda E I.Proudfoot Chemokine receptors:multifaceted therapeutic targets[J].Nat Rev Immunol,2002,(2):106-15.
  • 2Balkwill F.Cancer and the chemokine network[J].Nat Rev Cancer,2004,4 (7):540-50.
  • 3Strizki J M,Xu S,Wagner N E,et al.SCH-C (SCH351125),an orally bioavailable,small molecule antagonist of the chemokine receptor CCR5,is a potent inhibitor of HIV-1 infection in vitro and in vivo[J].Proc Natl A cad Sci USA,2001,98 (22):12718-23.
  • 4Harrison C,Traynor J R.The[35S]-GTPγS binding assay:approaches and applications in pharmacology[J].Life Sci,2003,74(4):489 -508.
  • 5Ferrer M,Kolodin G D,Zuck P,et al.A fully automated[35S]GTPγS scintillation proximity assay for the high-throughput screening of Gi-linked G protein-coupled receptors[J].Assay Drug Dev Technol,2003,1 (2):261-73.
  • 6Dallas-Yang Q,Qureshi S A,Xie D,Z,et al.Detection of glucagon-dependent GTPγS binding in high-throughput format[J],Anal Biochem,2002,301 (1):156 -9.
  • 7Gonsiorek W,Zavodny P,Hipkin R W.The study of CXCR3 and CCR7 pharmacology using[^35 S]-GTPγS exchange assays in cell membranes and permeabilized peripheral blood lymphocytes[J].J Immunol Methods,2003,273 (1-2):15-27.
  • 8De Lapp N W,McKinzie J H,Sawyer B D,et al.Determination of[35S]guanosine-5'-O-(3-thio) triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamstcr ovary cells and rat striatum using an anti-G protein scintillation proximity assay[J].J Pharmacol Exp Ther,1999,289 (2):946 -55.
  • 9Milligan G.Principles:extending the utility of[35S]GTPγS binding assays[J].Trends Pharmacol Sci,2003,24 (2):87-90.
  • 10许治良,高虹,欧阳克清,郑旭煦,蔡昭皙,胡应和.G-蛋白偶联受体的功能测定和高通量药物筛选[J].中国药理学通报,2003,19(12):1330-1365. 被引量:12

二级参考文献25

  • 1Landro JA, Taylor IC, Stirtan WG et al. HTS in the new millennium: The role of pharmacology and flexibility. J Pharmacol Toxicol Methods, 2000;44(1):273~89
  • 2Mellentin-Michelotti J, Evangelista LT, Swartzman EE et al. Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology. Anal Biochem, 1999;272(2):182~90
  • 3Banks P, Gosselin M, Prystay L. Fluorescence polarization assays for high throughput screening of G protein-coupled receptors. J Biomol Screen, 2000;5(3):159~68
  • 4Chiulli AC, Trompeter K, Palmer M. A novel high throughput chemiluminescent assay for the measurement of cellular cyclic adenosine monophosphate levels. J Biomol Screen, 2000;5(4):239~48
  • 5Cook ND, Jessop RA, Robinson PS et al. Scintillation proximity enzyme assay. A rapid and novel assay technique applied to HIV proteinase. Adv Exp Med Biol, 1991;306:525~8
  • 6Nuttall ME, Lee JC, Murdock PR et al. Amphibian melanophore technology as a functional screen for antagonists of G-protein coupled 7-transmembrane receptors. J Biomol Screen, 1999;4(5):269~78
  • 7Lerner MR. Tools for investigating functional interactions between ligands and G-protein-coupled receptors. Trends Neurosci,1994;17(4):142~6
  • 8Terstappen GC, Giacometti A, Ballini E, Aldegheri L. Development of a functional reporter gene HTS assay for the identification of mGluR7 modulators. J Biomol Screen, 2000;5(4):255~62
  • 9Goetz AS, Andrews JL, Littleton TR, Ignar DM. Development of a facile method for high throughput screening with reporter gene assays. J Biomol Screen, 2000;5(5):377~84
  • 10Weyer U, Schafer R, Himmler A et al. Establishment of a cellular assay system for G protein-linked receptors: Coupling of human NK2 and 5-HT2 receptors to phospholipase C activates a luciferase reporter gene. Receptors Channels, 1993;1(3):193~200

共引文献11

同被引文献14

  • 1胡政,靳艳,袁景利,王桂兰,张卫,邓麦村.一种可用于天然产物粗提物的HIV-1逆转录酶抑制剂筛选方法[J].中国药理学通报,2006,22(5):639-640. 被引量:1
  • 2Daar E S,Richman D D.Confronting the emergence of drug-resistant HIV type 1:impact of antiretroviral therapy on individual and population resistance[J].AIDS Res Hum Retroviruses,2005,21(5):343-57.
  • 3Clavel F,Hance A J.HIV drug resistance[J].N Engl J Med,2004,350(10):1023-35.
  • 4Roques B P,Morellet N,Rocquigny H,et al.Structure,biological functions and inhibition of the HIV-1 proteins Vpr and NCp7[J].Biochimie,1997,79(11):673-80.
  • 5Hermann S,Gebhard V J.Tricine-sodium dodecyl sulfate-polyacrylamide gel electro-phor esis for the separation of protein in the range from 1to 100 KDa[J].Analy Biochem,1987,166:368-79.
  • 6Beerheide W,Bernard H G,Tan Y L,et al.Potential drugs against cervical cancer:zinc-ejecting inhibitor of the human papillomavirus type 16 E6 oncoprotein[J].J Natl cancer inst,1999,91(14):1211-20.
  • 7Rossio J L,Esser M T,Suryanarayana K,et al.Inactivation of human immuno-deficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins[J].J Virol,1998,72(10):7992-8001.
  • 8Tisne C,Roques B P,Dardel F.Specific recognition of primer tRNALys3 by HIV-1 nucleocapsid protein:involvement of the zinc fingers and the N-terminal basic extension[J].Biochimie,2003,85(5):557-61.
  • 9Manuela J R,John P M.Mechanism of nucleocapsid protein catalyzed structural isomerization of the dimerization initiation site of HIV-1[J].Biochemistry,2002,41(50):14762-70.
  • 10Mahmood N,Jhaumeer L S,Sampson J,et al.Anti-HIV activity and mechanism of action of macrocyclic diamide SRR-SB3[J].J Pharm Pharmacol,1998,50(12):1339-42.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部